Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/39891
Title: Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.
Authors: 
Keywords: 
Mesh: 
Issue Date: Jul-2017
Citation: J. Cancer Res. Clin. Oncol..2017 Jul;(143)7:1225-1233
Abstract: The ENEST1st sub-analysis presents data based on Philadelphia chromosome (Ph) status, i.e., Ph+ and Ph-/BCR-ABL1 + chronic myeloid leukemia.
PMID: 28224300
URI: https://hdl.handle.net/20.500.12530/39891
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC5486575.pdf994.9 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.